The Effect of RF Genicular Nerve Block Applied in the Preoperative Period on Fast-track Total Knee Arthroplasty
Launched by PAMUKKALE UNIVERSITY · Jan 25, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a specific treatment called radiofrequency (RF) genicular nerve block, which is applied before knee surgery to see if it helps patients recover faster after total knee arthroplasty (TKA). The goal is to find out if this approach can reduce pain, improve function, and allow patients to go home sooner after their surgery. The study is currently recruiting participants aged between 40 and 85 who are scheduled for knee surgery due to osteoarthritis, a condition that causes pain and stiffness in the knee.
To be eligible for the trial, participants need to be able to understand and speak Turkish, and they should be having surgery on just one knee. However, people with certain health issues, such as previous major surgeries on the same leg, severe arthritis, or those with psychiatric disorders or other serious medical conditions, cannot participate. If you join the study, you can expect to receive detailed information about the trial, and you'll be closely monitored during your recovery to see how well the treatment works. This research could help improve care for future knee surgery patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being between the ages of 40 and 85,
- • Being able to understand verbal and written information given in Turkish,
- • Being able to speak and understand Turkish,
- • Being subjected to unilateral TKA surgery due to the diagnosis of Primary Knee osteoarthritis
- Exclusion Criteria:
- • Patients planned for revision knee prosthesis surgery,
- • Patients previously diagnosed with psychiatric disorders,
- • Patients who have undergone major surgery on the extremity where TKA will be applied,
- • Patients with comorbid diseases such as rheumatoid arthritis or cancer,
- • Patients with a score above 3 according to the American Society of Anesthesiologists (ASA) scoring,
- • Patients with neurological diseases that cause functional disability,
- • Patients with flexion limitation of more than 45 degrees and extension limitation of more than 20 degrees,
- • Patients who have to use hypnotic or anxiolytic drugs regularly,
- • Patients with alcohol or drug addiction,
- • Patients with bleeding disorders
- • Patients with uncontrolled diabetes
About Pamukkale University
Pamukkale University is a renowned academic institution located in Denizli, Turkey, dedicated to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative studies aimed at improving patient outcomes and contributing to the broader scientific community. With a commitment to ethical standards and regulatory compliance, Pamukkale University fosters collaboration among researchers, healthcare professionals, and industry partners, ensuring the rigorous execution of clinical trials that address critical health challenges. Through its research initiatives, the university aims to enhance the understanding of various medical conditions and support the development of effective therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Denizli, Pamukkale, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported